Pediatric intestinal failure: Nutrition, pharmacologic, and surgical approaches

被引:42
作者
Ching, Y. Avery [1 ]
Gura, Kathleen [1 ]
Modi, Biren [1 ]
Jaksic, Tom [1 ]
机构
[1] Childrens Hosp, Dept Surg, Boston, MA 02115 USA
关键词
D O I
10.1177/0115426507022006653
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Intestinal failure (IF) is a condition where there is insufficient functional bowel to allow for adequate nutrient and fluid absorption to sustain adequate growth in children. Several etiologies can predispose to IF, including necrotizing enterocolitis, gastroschisis, and intestinal atresias. Intestinal rehabilitation can be seen as a 3-pronged strategy merging nutrition, pharmacologic, and surgical approaches to achieve the ultimate goal of enteral nutrition. Nutrition approaches should seek to facilitate transition from parenteral nutrition (PN) to enteral nutrition because prolonged use of PN is associated with severe morbidity and mortality. Enteral nutrition, on the other hand, promotes and enhances an adaptive response in the intestine. Medications used in the treatment of IF may help alleviate symptoms of diarrhea, bacterial overgrowth, and gastrointestinal dysmotility. Surgical procedures, such as longitudinal intestinal lengthening and tapering (LILT) or serial transverse enteroplasty (STEP), can increase mucosal surface area and may enhance intestinal adaptation. IF is a difficult disease process with a complex patient population and is best guided through this 3-pronged approach by a multidisciplinary team featuring surgeons, gastroenterologists, dietitians, pharmacists, and nurses.
引用
收藏
页码:653 / 663
页数:11
相关论文
共 81 条
[11]   Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome - A prospective, randomized, placebo-controlled, double-blind clinical trial [J].
Byrne, TA ;
Wilmore, DW ;
Iyer, K ;
Dibaise, J ;
Clancy, K ;
Robinson, MK ;
Chang, P ;
Gertner, JM ;
Lautz, D .
ANNALS OF SURGERY, 2005, 242 (05) :655-661
[12]   Serial transverse enteroplasty enhances intestinal function in a model of short bowel syndrome [J].
Chang, RW ;
Javid, PJ ;
Oh, JT ;
Andreoli, S ;
Kim, HB ;
Fauza, D ;
Jaksic, T .
ANNALS OF SURGERY, 2006, 243 (02) :223-228
[13]  
COSNES J, 1992, NUTRITION, V8, P406
[14]   Effects of hyperosmolar agents - Lactulose, lactitol, sodium phosphate and polyethylene glycol - on cecal coliform bacteria during traditional bowel cleansing: An experimental study in rats [J].
Demirogullari, B ;
Poyraz, A ;
Cirak, MY ;
Sonmez, K ;
Ozen, IO ;
Kulah, C ;
Karabulut, B ;
Basaklar, AC ;
Kale, N .
EUROPEAN SURGICAL RESEARCH, 2004, 36 (03) :159-164
[15]   Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome [J].
DiBaise, JK ;
Young, RJ ;
Vanderhoof, JA .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (01) :11-20
[16]   Induction of intestinal epithelial proliferation by glucagon-like peptide 2 [J].
Drucker, DJ ;
Ehrlich, P ;
Asa, SL ;
Brubaker, PL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7911-7916
[17]   Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome [J].
Ellegard, L ;
Bosaeus, I ;
Nordgren, S ;
Bengtsson, BA .
ANNALS OF SURGERY, 1997, 225 (01) :88-96
[18]   Structure and metabolic fate of triacylglycerol- and phospholipid-rich particles of commercial parenteral fat emulsions [J].
Ferezou, J ;
Bach, AC .
NUTRITION, 1999, 15 (01) :44-50
[19]   SEQUENTIAL INTESTINAL LENGTHENING PROCEDURES FOR REFRACTORY SHORT-BOWEL SYNDROME [J].
GEORGESON, K ;
HALPIN, D ;
FIGUEROA, R ;
VINCENTE, Y ;
HARDIN, W .
JOURNAL OF PEDIATRIC SURGERY, 1994, 29 (02) :316-321
[20]   Irreversible intestinal failure [J].
Goulet, O ;
Ruemmele, F ;
Lacaille, F ;
Colomb, V .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2004, 38 (03) :250-269